Karo Pharma Smart choices for everyday healthcare About Products Karo Everyday Investors News & Press English The share Largest shareholders After the rights issue has been completed, which was registered November 1, 2019, the total number of shares are 225 033 204. Largest shareholder in Karo Pharma is Karo Intressenter AB with 179 684 209 shares, which is 79,8% of the number of shares. Shareholders on 31-10-2021 De största aktieägarna Innehav Röster i % KARO INTRESSENTER AB 179 684 209 79.85% FÖRSÄKRINGSAKTIEBOLAGET, AVANZA PENSION 3 161 149 1,40% STATE STREET BANK AND TRUST CO, W9 2 587 394 1,15% SIX SIS AG, W8IMY 1 783 735 0,79% CBNY-NORGES BANK 1 347 978 0,6% SEB Investment Management 1 320 482 0,59% FÖRSÄKRINGSAKTIEBOLAGET SKANDIA (PUB) 1 062 077 0,47% Handelsbanken fonder 884 256 0,39% BANQUE PICTET & CIE (EUROPE) SA, W8IMY 874 050 0,39% JP MORGAN CHASE BANK N.A. 624 746 0,28% Summa 10 största aktieägare 193 330 076 85,91% Övriga aktieägare 31 703 128 14,09% SUMMA 225 033 204 100,0% De största förändringarna Förändring Förändring i % Innehav KARO INTRESSENTER AB 2 017 377 1,1% 179 684 209 SWEDBANK AB -1 960 670 -100,0% 0 SEB AB, LUXEMBOURG BRANCH, W8IMY 221 724 100% 221 724 SIX SIS AG, W8IMY -221 724 -11,1% 1 783 735 ÅLANDSBANKEN I ÄGARES STÄLLE -207 479 -100% 0 Antal ägare Antal aktieägare 7 071 Nytillkomna aktieägare 76 Upphört att vara aktieägare 128 Insider trading For insiders and insider trading, please see Finansinspektionen’s register. Products Financial reports Financial Press releases Contact Karo Pharma Follow us on LinkedIn Copyright© Karo Pharma AB 2021 Cookies are required for our website to function optimally and to improve the user experience. By browsing further, you accept our use of cookies.» Privacy policy Approve

Karo Pharma Smart choices for everyday healthcare About Products Karo Everyday Investors News & Press English Public tender offer Information about EQT VIII public tender offer On January 2th 2019 EQT VIII decided to increase its public cash offer to the shareholders in Karo Pharma Aktiebolag from SEK 36.90 in cash per share to SEK 38.00 in cash per share. Related documents Karo Intressenter AB increases the offer price Statement by the Board of Directors in relation to the increased public offer Press release re-extension of acceptance period Karo Intressenter AB Offer document EQT press release public cash offer The Board of Directors recommendation to accept the offer Products Financial reports Financial Press releases Contact Karo Pharma Follow us on LinkedIn Copyright© Karo Pharma AB 2021 Cookies are required for our website to function optimally and to improve the user experience. By browsing further, you accept our use of cookies.» Privacy policy Approve